Article tools
Author information
Published in Volume 98, Issue 12 (December 15,1996)
J. Clin. Invest. 98(12): 2866-2873 (1996). doi:10.1172/JCI119115.
Copyright © 1996, The American Society for Clinical Investigation.

Research Article

Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.

M Sata and M Ikebe

Department of Physiology, University of Massachusetts Medical Center, Worcester 01655-0127, USA.

Published December 15, 1996

More than 30 missense mutations in the beta-cardiac myosin heavy chain gene have been shown to be responsible for familial hypertrophic cardiomyopathy. To clarify the effects of these point mutations on myosin motor function, we expressed wild-type and mutant human beta-cardiac myosin heavy chains in insect cells with human cardiac light chains. The wild-type myosin was well purified with similar enzymatic and motor activities to those of the naturally isolated V3 cardiac myosin. Arg249-->Gln and Arg453-->Cys mutations resulted in decreased actin translocating activity (61 and 23% of the wild-type, respectively) with decreased intrinsic ATPase activity. Arg403-->Gln mutation greatly decreased actin translocating activity (27% of wild type) with a 3.3-fold increased dissociation constant for actin, while intrinsic ATPase activity was unchanged. Val606-->Met mutation only mildly affected the actin translocating activity as well as ATPase activity of myosin. The degree of deterioration by each mutation was closely correlated with the prognosis of the affected kindreds, indicating that myosin dysfunction caused by the point mutations is responsible for the pathogenesis of the disease. Structure/function relationship of myosin is discussed.

This article Copyright © 1996, The American Society for Clinical Investigation.

Articles that cite
this article:

Die genetischen Ursachen der hypertrophischen Kardiomyopathie
Hans -Peter Vosberg
Med Klin 93(4):252. [CrossRef]

Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
Timothy E. Hewett, Bradley M. Palmer, Charlotte Olsson, Stephen M. Factor, Jil C. Tardiff, Russell L. Moore, Jeffrey Robbins, Leslie A. Leinwand
J Clin Invest 104(4):469. [CrossRef]

Altered cardiac excitation–contraction coupling in mutant mice with familial hypertrophic cardiomyopathy
Wei Dong Gao, Nestor Gustavo Pérez, Christine E. Seidman, Jonathan G. Seidman, Eduardo Marbán
J Clin Invest 103(5):661. [CrossRef]

Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene
Diane Fatkin, Michael E. Christe, Orlando Aristizabal, Bradley K. Mcconnell, Shardha Srinivasan, Frederick J. Schoen, Christine E. Seidman, Daniel H. Turnbull, J.G. Seidman
J Clin Invest 103(1):147. [CrossRef]

STRUCTURAL MECHANISM OF MUSCLE CONTRACTION>
M. A. Geeves, K. C. Holmes
Annu Rev Biochem 68(1):687. [CrossRef]

Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes
Jil C. Tardiff
Heart Fail Rev 10(3):237. [CrossRef]

Inactivation of myosin heavy chain genes in the mouse: Diverse and unexpected phenotypes
David L. Allen, Brooke C. Harrison, Leslie A. Leinwand
Microsc Res Tech 50(6):492. [CrossRef]

IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease
P. Skyllouriotis, M. Skyllouriotis-lazarou, S. Natter, R. Steiner, S. Spitzauer, S. Kapiotis, P. Valent, A. M. Hirschl, S. E. Guber, G. Laufer
Clin Exp Immunol 115(2):236. [CrossRef]

Hypertrophic cardiomyopathy: from gene defect to clinical disease
Man-Wei Chung, Tatiana Tsoutsman, Christopher Semsarian
Cell Res 13(1):9. [CrossRef]

Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
RONNY Alcalai, JONATHAN G. Seidman, CHRISTINE E. Seidman
J Cardiovasc Electrophysiol 0(0):071004055652012. [CrossRef]

Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy
Christina Grundt, Hans-Joerg Hippe, Benedikt Brors, Derk Frank, Uta Haselmann, Claude Antony, Mirko Voelkers, Mark Luedde, Ulrich Flögel, Maike Knorr
J Mol Med 87(4):411. [CrossRef]